This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Geadic Biotec, Aie. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Cristina Perez - Innovator in Endometrial Cancer Detection
Introduction
Cristina Perez is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of medical diagnostics, particularly in the detection of endometrial cancer. Her innovative work has the potential to improve early detection and treatment outcomes for patients.
Latest Patents
Cristina holds a patent for her invention titled "Markers for Endometrial Cancer." This invention is based on the discovery that specific biomarkers, including ACAA1, AP1M2, CGN, DDR1, EPS8L2, FASTKD1, GMIP, IKBKE, P2RX4, P4HB, PHKG2, PPFIBP2, PPP1 R16A, RASSF7, RNF183, SIRT6, TJP3, EFEMP2, S0CS2, and DCN, are differentially expressed in samples from patients with endometrial cancer compared to control samples. These biomarkers demonstrate excellent sensitivity and specificity, making them valuable for detecting the disease. Furthermore, the correlation between biomarker expression in tumor tissue and uterine fluid samples enhances their robustness for clinical use.
Career Highlights
Cristina is currently associated with Geadic Biotec, a company focused on biotechnological innovations. Her work at Geadic Biotec has been instrumental in advancing research and development in cancer diagnostics. With her expertise, she continues to contribute to the scientific community and improve patient care.
Collaborations
Cristina collaborates with notable professionals in her field, including Miguel Abal Posada and Andreas Doll. These partnerships enhance her research efforts and foster innovation in cancer detection technologies.
Conclusion
Cristina Perez is a trailblazer in the field of endometrial cancer detection, with her patented biomarkers offering promising advancements in medical diagnostics. Her dedication to innovation and collaboration continues to pave the way for improved healthcare solutions.